Evidence map›Paper›PMID 40246378›Full record

ReviewJACC. CardioOncology2025

Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council Perspective.

Vijay U Rao, Anita Deswal, Daniel Lenihan, Susan Dent, Teresa Lopez-Fernandez, Alexander R Lyon, Ana Barac, Nicolas Palaskas, Ming Hui Chen, Hector R Villarraga and 14 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in JACC. CardioOncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Cardiac monitoring in adolescent and young adult cancer patients treated with anthracyclines: a longitudinal descriptive study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Article
  5. Article
  6. Research Priorities and Future Directions in Cardio-Oncology.Current treatment options in oncology · 2026
    Review
  7. Integrated Cardio-oncology Service.Cardiac failure review · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Vijay U RaoFranciscan Cardio-Oncology Center, Franciscan Health, Indianapolis, Indiana, USA. Electronic address: veej7474@hotmail.com.
Anita DeswalDepartment of Cardiology, Division of Internal Medicine, MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: https://twitter.com/anita_deswal.
Daniel LenihanSt Francis Healthcare, Cape Girardeau, Missouri, USA.
Susan DentDuke Cancer Institute, Department of Medicine, Duke University, Durham, North Carolina, USA. Electronic address: https://twitter.com/sdent_cardioonc.
Teresa Lopez-FernandezDivision of Cardiology, Cardiac Imaging and Cardio-Oncology Unit, La Paz University Hospital, IdiPAZ Research Institute, Madrid, Spain; Division of Cardiology, Cardio-Oncology Unit, Quironsalud Madrid University Hospital, Madrid, Spain. Electronic address: https://twitter.com/TeresaLpezFdez1.
Alexander R LyonRoyal Brompton Hospital, London, United Kingdom.
Ana BaracInova Schar Heart and Vascular, Inova Schar Cancer, Falls Church, Virginia, USA. Electronic address: https://twitter.com/AnaBaracCardio.
Nicolas PalaskasDepartment of Cardiology, Division of Internal Medicine, MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: https://twitter.com/PalaskasN.
Ming Hui ChenCardiovascular Health for Cancer Survivors Program, Department of Cardiology, Division of Genetics and Genomics, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Electronic address: https://twitter.com/DrMingHuiChen.
Hector R VillarragaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Diego SadlerCleveland Clinic Florida, Department of Cardiovascular Medicine, Weston, Florida, USA. Electronic address: https://twitter.com/DSadlerMD.
Courtney M CampbellCardio-Oncology Center, Baylor Scott & White Heart and Vascular Hospital, Dallas, Texas, USA. Electronic address: https://twitter.com/CampbellMDPhD.
Kerry SkurkaCardio-Oncology Nurse/Program Consultant, ICOS Co-Chair Nursing Leadership, Leadership team: Advocacy, Survivorship, and Center of Excellence. Electronic address: https://twitter.com/KerrySkurka.
Matt J WagnerPatient Advocate.
Matthias TotzeckUniversity Hospital Essen, Clinic for Cardiology and Vascular Medicine, Essen, Germany. Electronic address: https://twitter.com/matthiastotzeck.
Kathryn J RuddyDepartment of Oncology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: https://twitter.com/KathrynRuddyMD.
Paul HeidenreichDivision of Cardiovascular Medicine, Stanford, California, USA. Electronic address: https://twitter.com/paheidenreich.
Randal ThomasDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Daniel AddisonThe Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Electronic address: https://twitter.com/md_addison.
Sarju GanatraCardio-Oncology Program, Division of Cardiovascular Medicine, Department of Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA. Electronic address: https://twitter.com/SarjuGanatraMD.
Richard ChengDivision of Cardiology, University of Washington, Seattle, Washington, USA. Electronic address: https://twitter.com/Richardkcheng2.
David ReevesFranciscan Health, Division of Oncology, Franciscan Health, Indianapolis, Indiana, USA; Butler University College of Pharmacy and Health Sciences, Indianapolis, Indiana, USA.
Arjun K GhoshBarts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Hatter Cardiovascular Institute, University College London Hospital, London, United Kingdom. Electronic address: https://twitter.com/arjunkg.
Joerg HerrmannDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: herrmann.joerg@mayo.edu.

Funding

TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) TrialR01CA233610 · NCI · MAYO CLINIC ROCHESTER · PI HERRMANN, JOERG, RUDDY, KATHRYN JEAN · 2019 to 2024
$4.3M
NCI NIH HHS R01 CA233610
6 · The paper itself

Abstract

This document serves as a perspective on quality assessments in the discipline of cardio-oncology. We aim to define the current landscape, identify needs for quality and outcome improvements, and propose a roadmap for establishing viable metrics to improve patient care. Specifically, this document: 1) addresses the current lack of measurable high-quality metrics in cardio-oncology and their implications; 2) highlights needs and topic-specific barriers; 3) illustrates the process and application of a measurable quality metric; and 4) provides a framework to demonstrate measurable value for the growing population of patients with cancer and cardiovascular diseases.

Indexed as

anthracyclinecancer survivorshipechocardiographyguidelinesHer2 therapyoutcomespreventionrisk factor

Identifiers

PMID40246378
PMCPMC12046809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.